Diabetic hypertensive patients: Is this a group in need of particular care and attention?

Diabetes Care

Volumn 22, Issue SUPPL. 2, 1999, Pages

  Parving, Hans Henrik ^a  

^a STENO DIABETES CENTER   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; LISINOPRIL; NISOLDIPINE;

ANTIHYPERTENSIVE THERAPY; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CONFERENCE PAPER; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DIABETIC RETINOPATHY; HUMAN; HYPERTENSION; MICROALBUMINURIA; MORTALITY; RISK FACTOR;

ALBUMINURIA; ANTIHYPERTENSIVE AGENTS; DIABETES COMPLICATIONS; DIABETES MELLITUS; DIABETIC NEPHROPATHIES; HUMANS; HYPERTENSION; PREVALENCE; RISK FACTORS; WORLD HEALTH ORGANIZATION;

EID: 0032972484     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (37)

1. Parving H-H, Østerby R, Anderson PW, Hsueh WA: Diabetic nephropathy. In The Kidney. Brenner BM, Ed. Philadelphia. Saunders, 1996, p. 1864-1892
2. Consensus Statement: Treatment of hypertension in diabetes. Diabetes Care 16:1394-1401, 1993
3. Gall M-A, Borch-Johnsen K, Hougaard P, Nielsen FS, Parving H-H: Albuminuria and poor glycemic control predicts mortality in NIDDM. Diabetes 44:1303-1309, 1995
4. Rossing P, Hougaard P, Borch-Johnsen K, Parving H-H: Predictors of mortality in insulin dependent diabetes: 10 year follow-up study. BMJ 313:779-784, 1996
5. Tarnow L, Rossing P, Gall M-A, Nielsen FS, Parving H-H: Prevalence of arterial hypertension in diabetic patients before and alter the JNC-V. Diabetes Care 17:1247-1251, 1994
6. Hansen KW, Christensen CK, Andersen PH, Mau Pedersen M, Christiansen JS, Mogensen CE: Ambulatory blood pressure in microalbuminuric type 1 diabetic patients. Kidney Int 41:847-854, 1992
7. Nielsen FS, Rossing P, Bang LE, Svendsen TL, Gall M-A, Smidt UM, Parving H-H: On the mechanisms of blunted nocturnal decline in arterial blood pressure in NIDDM patients with diabetic nephropathy. Diabetes 44:783-789, 1995
8. Karlefors T: Exercise test in male diabetics. Acta Med Scand 180 (Suppl. 449):3-43, 1966
9. Mathiesen ER, Gall M-A, Hommel E, Skøtt P, Parving H-H: Effects of short-term strict metabolic control on kidney function and extracellular fluid volume in incipient diabetic nephropathy. Diabet Med 6:595-600, 1989
10. Miller JA, Floras JS, Zinman B, Skorecki KL, Logan AG: Effect of hyperglycaemia on arterial pressure, plasma renin activity and renal function in early diabetes. Clin Sci 90:189-195, 1996
11. Kastrup J, Nørgaard T, Parving H-H, Henriksen O, Lassen NA: Impaired autoregulation of blood flow in subcutaneous tissue of long-term type 1 (insulin-dependent) diabetic patients with microangiopathy: an index of arteriolar dysfunction. Diabetologia 28:711-717, 1985
12. Kastrup J, Rørsgård S, Parving H-H, Lassen NA: Impaired autoregulation of cerebral blood flow in long-term type 1 (insulin-dependent) diabetic patients with nephropathy and retinopathy. Clin Physiol 6:549-559, 1986
13. Parsing H-H, Kastrup J, Smidt UM, Andersen AR, Feldt-Rasmussen B, Christiansen JS: Impaired autoregulation of glomerular filtration rate in type 1 (insulin-dependent) diabetic patients with nephropathy. Diabetologia 27:547-552, 1984
14. Sandeman DD, Shore AC, Tooke JF: Relation of skin capillary pressure in patients with insulin-dependent diabetes mellitus to complications and metabolic control. N Engl J Med 327:760-764, 1992
15. Shore AC, Jaap AJ, Tooke JE: Capillary pressure in patients with NIDDM. Diabetes 43:1198-1202, 1994
16. Puig JG, Ruilope LM, Ortega R: Antihypertensive treatment efficacy in type II diabetes mellitus: dissociation between causal and 24-hour ambulatory blood pressure. Hypertension 26:1093-1099, 1995
17. Nielsen FS, Gaede P, Vedel P, Pedersen OB, Parving H-H: White coat hypertension in NIDDM patients with and without incipient and overt diabetic nephropathy. Diabetes Care 20:859-863, 1997
18. Warram JH, Laffel L, Valsania P, Christlieb AR, Krolewski AS: Excess mortality associated with diuretic therapy in diabetes mellitus. Arch Intern Med 51:1350-1356, 1991
19. Diabetic Retinopathy Study Research Group: Report 7: a modification of the Airlie House classification of diabetic retinopathy. Invest Ophthalmol Vis Sci 21:210-226, 1981
20. Diabetic Retinopathy Study Research Group: Report number 6: design, methods, and baseline results. Invest Ophthalmol Vis Sci 21:3-188, 1981
21. Klein R, Moss SE, Klein BEK, DeMets DL: Relation of ocular and systemic factors to survival in diabetes. Arch Intern Med 149:266-272, 1989
22. Curb JD, Pressel SL, Cutler JA, Savage PJ, Appelgate WB, Black H, Camel G, Davis BR, Frost PH, Gonzalez N, Guthrie G, Oberman A, Rutan GH, Stamler J: Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension. JAMA 276:1886-1892, 1996
23. Parving H-H, Tarnow L, Rossing P: Renal protection in diabetes: an emerging role for calcium antagonists. J Hypertens 14:S21-S25, 1996
24. Bakris GL, Copley JB, Vicknair N, Sadler R, Leugans S: Calcium channel blockers versus other antihypertensive therapies on progression of NIDDM associated nephropathy. Kidney Int 50:1641-1650, 1996
25. Bakris GL, Mangrum A, Copley JB, Vicknair N, Sadler R: Effect of calcium channel or β-blockade on the progression of diabetic nephropathy in African Americans. Hypertension 29:744-750, 1997
26. Rossing P, Tamow L, Boelskifte S, Jensen BR, Nielsen FS, Parving H-H: Differences between nisoldipine and lisinopril on glomerular filtration rates and albuminuria in hypertensive IDDM patients with diabetic nephropathy during the first year of treatment. Diabetes 46:481-487, 1997
27. Björck S, Nyberg G, Mulec H, Granerus G, Herlitz H, Aurell M: Beneficial effect of angiotensin converting enzyme inhibition on renal function in patients with diabetic nephropathy. Br Med J 293:471-474, 1986
28. Lewis E, Hunsicker L, Bain R, Rhode R: The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. N Engl J Med 329:1456-1462, 1993
29. Mogensen CE: Long-term antihypertensive treatment inhibiting progression of diabetic nephropathy. Br Med J 285:685-688, 1982
30. Nielsen FS, Rossing P, Gall M-A, Skøtt P, Smidt UM, Parving H-H: Impact of lisinopril and atenolol on kidney function in hypertensive NIDDM subjects with diabetic nephropathy. Diabetes 43:1108-1113, 1994
31. Nielsen FS, Rossing P, Gall M-A, Skøtt P, Smidt UM, Parving H-H: Long-term effect of lisinopril and atenolol on kidney function in hypertensive non-insulin-dependent diabetic subjects with diabetic nephropathy. Diabetes 46:1182-1188, 1997
32. Parving H-H, Andersen AR, Smidt UM, Svendsen PA: Early aggressive antihypertensive treatment reduces rate of decline in kidney function in diabetic nephropathy. Lancet i:1175-1179, 1983
33. Parving H-H, Hommel E: Prognosis in diabetic nephropathy. BMJ 299:230-233, 1989
34. Parving H-H, Jacobsen P, Rossing K, Smidt UM, Hommel E, Rossing P: Benefits of long-term antihypertensive treatment on prognosis in diabetic nephropathy. Kidney Int 49:1778-1782, 1996
35. Knowles HCJ: Long term juvenile diabetes treated with unmeasured diet. Trans Assoc Am Physicians 84:95-101, 1971
36. Andersen AR, Christiansen JS, Andersen JK, Kreiner S, Deckert T: Diabetic nephropathy in type 1 (insulin-dependent) diabetes: an epidemiological study. Diabetologia 25:496-501, 1983
37. Krolewski AS, Warram JH, Christheb AR, Busick EJ, Kahn CR: The changing natural history of nephropathy in type 1 diabetes. Am J Med 78:785-794, 1985